Statistical association of basal cell keratins with metastasis-inducing proteins in a prognostically unfavorable group of sporadic breast cancers

American Journal of Pathology

Volumn 179, Issue 2, 2011, Pages 1061-1072

  De Silva Rudland, Suzete ^a   Platt Higgins, Angela ^a   Winstanley, John H R ^b   Jones, Nigel J ^a   Barraclough, Roger ^a   West, Christopher ^a   Carroll, Joseph ^a   Rudland, Philip S ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL BOLTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTERIOR GRADIENT 2; CALVASCULIN; CYTOKERATIN 14; CYTOKERATIN 5; CYTOKERATIN 6; FANCONI ANEMIA GROUP D2 PROTEIN; METASTASIS INDUCING PROTEIN; OSTEOPONTIN; PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; DNA REPAIR; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPH NODES; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM METASTASIS; NEOPLASMS, BASAL CELL; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 80052430383     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.04.022     Document Type: Article

References (76)

1. S.R. Wellings, H.M. Jensen, and R.G. Marcum An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions J Natl Cancer Inst 55 1975 231 273
2. D.L. Page, and T.J. Anderson Diagnostic Histopathology of the Breast 1988 Churchill Livingstone Edinburgh
3. T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J.S. Marron, A. Nobel, S. Deng, H. Johnsen, R. Pesich, S. Geisler, J. Demeter, C.M. Perou, P.E. Lønning, P.O. Brown, A.L. Børresen-Dale, and D. Botstein Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 2003 8418 8423 (Pubitemid 36842560)
4. R. Moll, W.W. Franke, D.L. Schiller, B. Geiger, and R. Krepler The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells Cell 31 1982 11 24 (Pubitemid 13215192)
5. S.H. Dairkee, B.H. Mayall, H.S. Smith, and A.J. Hackett Monoclonal marker that predicts early recurrence of breast cancer Lancet 1 8531 1987 514 (Pubitemid 17036538)
6. B.A. Gusterson, M.J. Warburton, D. Mitchell, M. Ellison, A.M. Neville, and P.S. Rudland Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast disease Cancer Res 42 1982 4763 4770 (Pubitemid 13205987)
7. P.S. Rudland, S.J. Leinster, J. Winstanley, B. Green, A. Atkinson, and H. Zakhour Immunocytochemical identification of cell types in benign and malignant breast diseases: variations in cell markers accompany the malignant state J Histochem Cytochem 41 1993 543 553 (Pubitemid 23094007)
8. D.M. Abd El-Rehim, S.E. Pinder, C.E. Parish, J. Bell, R.W. Blamey, J.F.R. Robertson, R.I. Nicholson, and I.O. Ellis Expression of luminal and basal cytokeratins in human breast carcinoma J Pathol 203 2004 661 671 (Pubitemid 38714103)
9. T.O. Nielsen, F.D. Hsu, K. Jensen, M. Cheong, G. Karaca, Z. Hu, T. Hernandez-Boussard, C. Livsey, D. Cowan, L. Dressler, L.A. Akslen, J. Ragaz, A.M. Gown, C.B. Gilks, M. van de Rijn, and C.M. Perou Immunohistochemical and clinical characterisation of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 2004 5367 5374 (Pubitemid 39100473)
10. K. Malzahn, M. Mitze, M. Thoenes, and R. Moll Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating breast carcinomas Virchows Arch 433 1998 119 129 (Pubitemid 28401168)
11. M. van de Rijn, C.M. Perou, R. Tibshirani, P. Haas, O. Kallioniemi, J. Kononen, J. Torhorst, G. Sauter, M. Zuber, O.R. Köchli, F. Mross, H. Dieterich, R. Seitz, D. Ross, D. Botstein, and P. Brown Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome [Erratum appeared in Am J Pathol 2003, 163:377] Am J Pathol 161 2002 1991 1996 (Pubitemid 35434844)
12. C. Fan, D.S. Oh, L. Wessels, B. Weigelt, D.S.A. Nuyten, A.B. Nobel, L.J. van't Veer, and C.M. Perou Concordance among gene-expression-based predictors for breast cancer N Engl J Med 355 2006 560 569 (Pubitemid 44200649)
13. D.J. Dunnington, P. Monaghan, C.M. Hughes, and P.S. Rudland Phenotypic instability of rat mammary tumor epithelial cells J Natl Cancer Inst 71 1983 1227 1240 (Pubitemid 14182055)
14. B.R. Davies, M.P.A. Davies, F.M. Gibbs, R. Barraclough, and P.S. Rudland Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1 Oncogene 8 1993 999 1008 (Pubitemid 23087433)
15. A.J. Oates, R. Barraclough, and P.S. Rudland The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model Oncogene 13 1996 97 104 (Pubitemid 26248549)
16. D. Liu, P.S. Rudland, D.R. Sibson, A. Platt-Higgins, and R. Barraclough Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas Cancer Res 65 2005 3796 3805 (Pubitemid 40616358)
17. G. Wang, A. Platt-Higgins, J. Carroll, S. de Silva Rudland, J. Winstanley, R. Barraclough, and P.S. Rudland Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients Cancer Res 66 2006 1199 1207 (Pubitemid 43165991)
18. P.S. Rudland, A. Platt-Higgins, C. Renshaw, C.R. West, J.H.R. Winstanley, L. Robertson, and R. Barraclough Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer Cancer Res 60 2000 1595 1603 (Pubitemid 30183430)
19. P.S. Rudland, A. Platt-Higgins, M. El-Tanani, S. de Silva Rudland, R. Barraclough, J.H.R. Winstanley, R. Howitt, and C.R. West Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer Cancer Res 62 2002 3417 3427 (Pubitemid 34651388)
20. D.L. Barraclough, A. Platt-Higgins, S. de Silva Rudland, R. Barraclough, J. Winstanley, C.R. West, and P.S. Rudland The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients Am J Pathol 175 2009 1848 1857
21. W. Wang Emergence of DNA-damage response network consisting of Fanconi anemia and BRCA proteins Nat Rev Genet 8 2007 735 748 (Pubitemid 47429206)
22. P.S. Rudland, A.M. Platt-Higgins, L.M. Davies, S. de Silva Rudland, J.B. Wilson, A. Aladwani, J. Winstanley, D.L. Barraclough, R. Barraclough, C.R. West, and N.J. Jones Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer Am J Pathol 176 2010 2935 2947
23. P.E. Purkis, J.B. Steele, I.C. Mackenzie, W.B. Nathrath, I.M. Leigh, and E.B. Lane Antibody markers of basal cells in complex epithelia J Cell Sci 97 1990 39 50 (Pubitemid 120023244)
24. S. de Silva Rudland, L. Martin, C. Roshanlall, J. Winstanley, S. Leinster, A. Platt-Higgins, J. Carroll, C. West, R. Barraclough, and P. Rudland Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer Clin Cancer Res 12 2006 1192 1200 (Pubitemid 43342508)
25. A.M. Platt-Higgins, C.A. Renshaw, C.R. West, J.H. Winstanley, S. De Silva Rudland, R. Barraclough, and P.S. Rudland Comparison of the metastasis-inducing protein S100A4 (p9Ka) with other prognostic markers in human breast cancer Int J Cancer 89 2000 198 208 (Pubitemid 30185931)
26. R. Leake, D. Barnes, S. Pinder, I. Ellis, E. Anderson, T. Anderson, R. Adamson, A. Rhodes, K. Miller, and R. Walker Immunohistochemical detection of steroid receptors in breast cancer: a working protocol UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC J Clin Pathol 53 2000 634 635
27. R.A. Walker, J.M. Bartlett, M. Dowsett, I.O. Ellis, A.M. Hanby, B. Jasani, K. Miller, and S.E. Pinder HER2 testing in the UK: further update to recommendations J Clin Pathol 61 2008 818 824 (Pubitemid 351969725)
28. L.M. McShane, D.G. Altman, W. Sauerbrei, S.E. Taube, M. Gion, G.M. Clark Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics REporting recommendations for tumour MARKer prognostic studies (REMARK) Eur J Cancer 41 2005 1690 1696 (Pubitemid 41132629)
29. W.J. Conover Practical Nonparametric Statistics ed 3 1999 Wiley London
30. E.A. Rakha, S.E. Elsheikh, M.A. Aleskandarany, H.O. Habashi, A.R. Green, D.G. Powe, M.E. El-Sayed, A. Benhasouna, J.S. Brunet, L.A. Akslen, A.J. Evans, R. Blamey, J.S. Reis-Filho, W.D. Foulkes, and I.O. Ellis Triple negative breast cancer: distinguishing between basal and nonbasal subtypes Clin Cancer Res 15 2009 2302 2310
31. R.B. Nagle, W. Böcker, and J.R. Davis Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells J Histochem Cytochem 34 1986 869 881 (Pubitemid 16067456)
32. R.H. Wetzels, H.J. Kuijpers, E.B. Lane, I.M. Leigh, S.M. Troyanovsky, R. Holland, U.J. van Haelst, and F.C. Ramaekers Basal cell-specific and hyperproliferation-related keratins in human cancer Am J Pathol 138 1991 751 763
33. S.R. Lakhani, J.S. Reis-Filho, L. Fulford, F. Penault-Llorca, M. van der Vijver, and S. Parry Breast Cancer Linkage Consortium: Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype Clin Cancer Res 11 2005 5175 5180 (Pubitemid 41003703)
34. L.G. Fulford, D.F. Easton, J.S. Reis-Filho, A. Sofronis, C.E. Gillett, S.R. Lakhani, and A. Hanby Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast Histopathology 49 2006 22 34 (Pubitemid 43972917)
35. M.C. Cheang, D. Voduc, C. Bajdik, S. Leung, S. McKinney, S.K. Chia, C.M. Perou, and T.O. Nielsen Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype Clin Cancer Res 14 2008 1368 1376 (Pubitemid 351413917)
36. E.A. Rakha, J.S. Reis-Filho, and I.O. Ellis Basal-like breast cancer: a critical review J Clin Oncol 26 2008 2568 2581
37. S.J. Dawson, E. Provenzano, and C. Caldas Triple negative breast cancers: clinical and prognostic implications Eur J Cancer 45 Suppl 1 2009 27 40
38. W.D. Foulkes, I.M. Stefansson, P.O. Chappuis, L.R. Bégin, J.R. Goffin, N. Wong, M. Trudel, and L.A. Akslen Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer J Natl Cancer Inst 95 2003 1482 1485 (Pubitemid 37279334)
39. E.A. Rakha, M.E. El-Sayed, A.H.S. Lee, C.W. Elston, M.J. Grainge, Z. Hodi, R.W. Blamey, and I.O. Ellis Prognostic significance of the Nottingham histologic grade in invasive breast carcinoma J Clin Oncol 26 2008 3153 3158
40. C.W. Elston, G.A. Gresham, G.S. Rao, T. Zebro, J.L. Haybittle, J. Houghton, and G. Kearney The Cancer Research Campaign (King's/Cambridge) Trial for early breast cancer: clinico-pathological aspects Br J Cancer 45 1982 655 669 (Pubitemid 12122855)
41. J. Winstanley, T. Cooke, G.D. Murray, A. Platt-Higgins, W.D. George, S. Holt, M. Myskov, A. Spedding, B.R. Barraclough, and P.S. Rudland The long term prognostic significance of c-erbB-2 in primary breast cancer Br J Cancer 63 1991 447 450
42. M.P.A. Davies, D.L. Barraclough, C. Stewart, K.A. Joyce, R.M. Eccles, R. Barraclough, P.S. Rudland, and D.R. Sibson Expression and splicing of the unfolded response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer Int J Cancer 123 2008 85 88 (Pubitemid 351705195)
43. F. Podo, L.M. Buydens, H. Degani, R. Hilhorst, E. Klipp, I.S. Gribbestad, S. Van Huffel, H.W. van Laarhoven, J. Luts, D. Monleon, G.J. Postma, N. Schneiderhan-Marra, F. Santoro, H. Wouters, H.G. Russnes, T. Sørlie, E. Tagliabue, A.L. Børresen-Dale FEMME Consortium Triple-negative breast cancer: present challenges and new perspectives Mol Oncol 4 2010 209 229
44. T. Taniguchi, I. Garcia-Higuera, P.R. Andreassen, R.C. Gregory, M. Grompe, and A.D. D'Andrea S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51 Blood 100 2002 2414 2420
45. C. Jones, A.V. Nonni, L. Fulford, S. Merrett, R. Chagger, U. Eusebi, and S.R. Lakhani CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation Br J Cancer 85 2001 422 427 (Pubitemid 32747712)
46. E. Korsching, J. Packeisen, K. Agelopoulos, M. Eisenacher, R. Voss, J. Isola, P.J. van Diest, B. Brandt, W. Boecker, and H. Buerger Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis Lab Invest 82 2002 1525 1533 (Pubitemid 35332911)
47. C.M. Perou, T. Sørlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, C.A. Rees, J.R. Pollack, D.T. Ross, H. Johnsen, L.A. Akslen, O. Fluge, A. Pergamenschikov, C. Williams, S.X. Zhu, P.E. Lønning, A.L. Børresen-Dale, P.O. Brown, and D. Botstein Molecular portraits of human breast tumours Nature 406 2000 747 752
48. T. Sørlie, C.M. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, T. Thorsen, H. Quist, J.C. Matese, P.O. Brown, D. Botstein, P. Eystein Lønning, and A.L. Børresen-Dale Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 2001 10869 10874
49. L.J. van 't Veer, H. Dai, M.J. van de Vijver, Y.D. He, A.A. Hart, M. Mao, H.L. Peterse, K. van der Kooy, M.J. Marton, A.T. Witteveen, G.J. Schreiber, R.M. Kerkhoven, C. Roberts, P.S. Linsley, R. Bernards, and S.H. Friend Gene expression profiling predicts clinical outcome of breast cancer Nature 415 2002 530 536 (Pubitemid 34130608)
50. D.L. Barraclough, S. Sewart, P.S. Rudland, B.S. Shoker, D.R. Sibson, R. Barraclough, and M.P. Davies Microarray analysis of suppression subtracted hybridisation libraries identifies genes associated with breast cancer progression Cell Oncol 32 2010 87 99
51. P.S. Rudland, and C.M. Hughes Immunocytochemical identification of cell types in human mammary gland: variations in cellular markers are dependent on glandular topography and differentiation J Histochem Cytochem 37 1989 1087 1100 (Pubitemid 19167291)
52. P.S. Rudland Histochemical organization and cellular composition of ductal buds in developing human breasts: evidence for cytological intermediates between epithelial and myoepithelial cells J Histochem Cytochem 39 1991 1471 1484
53. B.A. Gusterson, D.T. Ross, V.J. Heath, and T. Stein Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer Breast Cancer Res 7 2005 143 148 (Pubitemid 40872776)
54. W. Böcker, R. Moll, C. Poremba, R. Holland, P.J. Van Diest, P. Dervan, H. Brger, D. Wai, R. Ina Diallo, B. Brandt, H. Herbst, A. Schmidt, M.M. Lerch, and I.B. Buchwallow Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept Lab Invest 82 2002 737 746
55. W. Boecker, and H. Buerger Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept Cell Prolif 36 Suppl 1 2003 73 84 (Pubitemid 37521845)
56. P.S. Rudland, G. Ollerhead, and R. Barraclough Isolation of simian virus 40-transformed human mammary epithelial stem cell lines that can differentiate to myoepithelial-like cells in culture and in vivo Dev Biol 136 1989 167 180 (Pubitemid 19262694)
57. H. Clayton, I. Titley, and M. Vivanco Growth and differentiation of progenitor/stem cells derived from the human mammary gland [Erratum appeared in Exp Cell Res 2004;300:257] Exp Cell Res 297 2004 444 460 (Pubitemid 38798406)
58. E. Lim, F. Vaillant, D. Wu, N.C. Forrest, B. Pal, A.H. Hart, M.L. Asselin-Labat, D.E. Gyorki, T. Ward, A. Partanen, F. Feleppa, L.I. Huschtscha, H.J. Thorne, kConFab, S.B. Fox, M. Yan, J.D. French, M.A. Brown, G.K. Smyth, J.E. Visvader, and G.J. Lindeman Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers Nat Med 15 2009 907 913
59. D.C. Bennett, L.A. Peachey, H. Durbin, and P.S. Rudland A possible mammary stem cell line Cell 15 1978 283 298 (Pubitemid 9027532)
60. E.J. Ormerod, and P.S. Rudland Cellular composition and organisation of ductal buds in developing rat mammary glands: evidence for morphological intermediates between epithelial and myoepithelial cells Am J Anat 170 1984 631 652 (Pubitemid 14096968)
61. M.L. Asselin-Labat, M. Shackleton, J. Stingl, F. Vaillant, N.C. Forrest, C.J. Eaves, J.E. Visvader, and G.J. Lindeman Steroid hormone receptor status of mouse mammary stem cells J Natl Cancer Inst 98 2006 1011 1014 (Pubitemid 44288166)
62. P.S. Rudland Epithelial stem cells and their possible role in the development of the normal and diseased breast Histol Histopathol 8 1993 385 404 (Pubitemid 23125715)
63. F. Behbod, and J.M. Rosen Will cancer stem cells provide new therapeutic targets? Carcinogenesis 26 2005 703 711 (Pubitemid 41214332)
64. J. Stingl, and C. Caldas Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis Nat Rev Cancer 7 2007 791 799 (Pubitemid 47463670)
65. O.W. Petersen, T. Gudjonsson, R. Villadsen, M.J. Bissell, and L. Rønnov-Jessen Epithelial progenitor cell lines as models of normal breast morphogenesis and neoplasia Cell Prolif 36 Suppl 1 2003 33 44 (Pubitemid 37521842)
66. R.B. Clarke, K. Spence, E. Anderson, A. Howell, H. Okano, and C.S. Potten A putative breast stem cell population is enriched for steroid receptor-positive cells Dev Biol 277 2005 443 456 (Pubitemid 40022963)
67. E. Korsching, J. Packeisen, C. Liedtke, D. Hungermann, P. Wlfing, P.J. van Diest, B. Brandt, W. Boecker, and H. Buerger The origin of vimentin expression in invasive cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol 206 2005 451 457 (Pubitemid 41025348)
68. B.K. Abraham, P. Fritz, M. McClellan, P. Hauptvogel, M. Athelogou, and H. Brauch Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis Clin Cancer Res 11 2005 1154 1159 (Pubitemid 40175765)
69. C. Ginestier, M.H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, M. Brown, J. Jacquemier, P. Viens, C.G. Kleer, S. Liu, A. Schott, D. Hayes, D. Birnbaum, M.S. Wicha, and G. Dontu ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 2007 555 567 (Pubitemid 350056407)
70. M.H. Wright, A.M. Calcagno, C.D. Salcido, M.D. Carlson, S.V. Ambudkar, and L. Varticovski Brca1 breast tumors contain distinct CD44 +/CD24- and CD133+ cells with cancer stem cell characteristics Breast Cancer Res 10 2008 R10
71. G. Molyneux, F.C. Geyer, F.A. Magnay, A. McCarthy, H. Kendrick, R. Natrajan, A. Mackay, A. Grigoriadis, A. Tutt, A. Ashworth, J.S. Reis-Filho, and M.J. Smalley BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells Cell Stem Cell 7 2010 403 417
72. A.M. Hosey, J.J. Gorski, M.M. Murray, J.E. Quinn, W.Y. Chung, G.E. Stewart, C.R. James, S.M. Farragher, J.M. Mulligan, A.N. Scott, P.A. Dervan, P.G. Johnston, F.J. Couch, P.A. Daly, E. Kay, A. McCann, P.B. Mullan, and D.P. Harkin Molecular basis for estrogen receptor alpha deficiency on BRCA1-linked breast cancer J Natl Cancer Inst 99 2007 1683 1694 (Pubitemid 351767217)
73. J.J. Gorski, C.R. James, J.E. Quinn, G.E. Stewart, K.C. Staunton, N.E. Buckley, F.A. McDyer, R.D. Kennedy, R.H. Wilson, P.B. Mullan, and D.P. Harkin BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer Breast Cancer Res Treat 122 2010 721 731
74. S. Liu, C. Ginestier, E. Charafe-Jauffret, H. Foco, C.G. Kleer, S.D. Merajver, G. Dontu, and M.S. Wicha BRCA1 regulates human mammary stem cell progenitor cell fate Proc Natl Acad Sci USA 105 2008 1680 1685 (Pubitemid 351346574)
75. M.K. El-Tanani, F.C. Campbell, P. Crowe, P. Erwin, D.P. Harkin, P. Pharoah, B. Ponder, and P.S. Rudland BRCA1 suppresses osteopontin-mediated breast cancer J Biol Chem 281 2006 26587 26601 (Pubitemid 44401868)
76. P.S. Rudland, R. Barraclough, D.G. Fernig, and J.A. Smith Mammary stem cells in normal development and cancer Stem Cells C.S. Potten, 1996 Academic Press London 147 232